Before submission
Potential low-margin dispensing, available cost signals, and possible data anomalies can be difficult to catch in a busy workflow.
REMIVEXA is developing a pharmacy intelligence platform to help independent pharmacies identify potential claim concerns before submission and analyze reimbursement results after adjudication. Clearer signals, better-informed decisions.
Illustrative product concept. Metrics are fictitious, not customer data.
From unexpected reimbursement estimates to payment discrepancies, pharmacy teams need context at the moment it matters. REMIVEXA is being designed to support a more proactive workflow while preserving human review.
Potential low-margin dispensing, available cost signals, and possible data anomalies can be difficult to catch in a busy workflow.
Payer responses and reimbursements can create questions that need timely investigation, not assumptions.
Claims, remittances, and acquisition costs may live in different places, making trends and variances harder to understand.
Our roadmap connects proactive claim review with retrospective reimbursement intelligence. The availability of individual checks will depend on data sources, integrations, and validation.
Planned checks would highlight potential claim or pricing concerns before transmission, when the required information and workflow integration are available.
Compare available acquisition-cost and expected-payment inputs to help teams spot possible negative-margin scenarios before decisions are made.
Review adjudicated claims and payment trends to investigate potential variances after processing.
Explore reimbursement patterns across payers, PBMs, NDCs and time periods, subject to available data.
Bring supporting figures and relevant context together so teams can examine flags instead of relying on unexplained scores.
Developing practical tools designed to support existing pharmacy operations, without promising universal system integrations.
Claim intelligence is not a single report. Our planned approach addresses both pre-submission questions and post-adjudication investigation.
Using appropriate claim inputs, current cost data, and supported integrations, a future REMIVEXA workflow could alert staff to possible pricing, margin, or completeness issues before transmission. A flag is a prompt to investigate—not a prediction of adjudication or a reason to bypass payer requirements.
Planned functionality; integrations and checks are not yet generally available.
Teams could review reimbursement amounts, compare relevant costs, identify patterns and organize potential discrepancies for further assessment. Reimbursement outcomes and contractual entitlements depend on payer terms and underlying records.
Illustrative product direction; final workflows and reporting will evolve.
Your reimbursement data deserves more than a spreadsheet. We're creating a central place to explore the signals that matter.
Connect supported claim, cost, and reimbursement inputs through workflows that are still being designed.
Planned pre-submission checks could surface risk indicators for staff review; the pharmacy remains responsible for claim decisions.
Compare adjudicated reimbursement results with available costs and trends to support follow-up investigations.
Interested in pre-submission risk checks and reimbursement analytics? Contact our team about early access, planned features, and future updates.
Get occasional updates on REMIVEXA’s development. We’ll store your email to contact you about early access. See our Privacy Policy.
REMIVEXA is prelaunch. No subscriptions or payments are collected on this site.